U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H22N2O6S2
Molecular Weight 414.496
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of APRATASTAT

SMILES

CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)C2=CC=C(OCC#CCO)C=C2

InChI

InChIKey=MAVDNGWEBZTACC-HNNXBMFYSA-N
InChI=1S/C17H22N2O6S2/c1-17(2)15(16(21)18-22)19(9-12-26-17)27(23,24)14-7-5-13(6-8-14)25-11-4-3-10-20/h5-8,15,20,22H,9-12H2,1-2H3,(H,18,21)/t15-/m0/s1

HIDE SMILES / InChI

Molecular Formula C17H22N2O6S2
Molecular Weight 414.496
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Apratastat (Tmi 005) was developed by Wyeth Research as a dual TNF-alpha-converting enzyme and matrix metalloprotease-13 inhibitor for the treatment of rheumatoid arthritis. Apratastat was in phase II clinical trials, but because of the lack of efficacy, this trial was terminated.

Originator

Curator's Comment: # Wyeth Research

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P78536
Gene ID: 6868.0
Gene Symbol: ADAM17
Target Organism: Homo sapiens (Human)
Target ID: P45452
Gene ID: 4322.0
Gene Symbol: MMP13
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
2004 Apr
Drug evaluation: apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis.
2006 Nov
A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells.
2010 Jan 1
Pharmacokinetic-pharmacodynamic modeling of apratastat: a population-based approach.
2011 Apr

Sample Use Guides

Unknown
Route of Administration: Oral
Apratastat inhibited TNF-α release with a population mean IC(50) of 144 ng/mL in vitro
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:11:18 UTC 2023
Edited
by admin
on Fri Dec 15 16:11:18 UTC 2023
Record UNII
C6BZ5263BJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
APRATASTAT
INN   USAN  
INN   USAN  
Official Name English
TMI-005
Code English
3-THIOMORPHOLINECARBOXAMIDE, N-HYDROXY-4-((4-((4-HYDROXY-2-BUTYNYL)OXY)PHENYL)SULFONYL)-2,2-DIMETHYL, (3S)-
Common Name English
apratastat [INN]
Common Name English
(3S)-N-Hydroxy-4-[[4-[(4-hydroxybut-2-ynyl)oxy]phenyl]sulfonyl]-2,2-dimethylthiomorpholine-3-carboxamide
Systematic Name English
TMI-05
Code English
APRATASTAT [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1970
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL206815
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
USAN
QQ-22
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
EPA CompTox
DTXSID10870312
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
NCI_THESAURUS
C76767
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
SMS_ID
300000034147
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
FDA UNII
C6BZ5263BJ
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
CAS
287405-51-0
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
INN
8578
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
DRUG BANK
DB13020
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
PUBCHEM
11452716
Created by admin on Fri Dec 15 16:11:18 UTC 2023 , Edited by admin on Fri Dec 15 16:11:18 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY